Wegovy’s cash price comes from Novo Nordisk’s own pharmacy program, and it’s far below the list price. Through NovoCare Pharmacy, the pen costs $349 a month at every dose up to 2.4 mg, after an intro price of $199 for new patients [4]. The pill starts at $149. Insurance, the savings card and Medicare’s new GLP-1 Bridge can each change that number, as long as you know which one applies to you.
Which Wegovy price applies to you
| Situation | Price | Conditions | Source |
|---|---|---|---|
| Cash, pen, new patient, 0.25 or 0.5 mg | $199 a month | First 2 monthly fills, through December 31, 2026 | NovoCare [4] |
| Cash, pen, 0.25 to 2.4 mg | $349 a month | After the intro fills | NovoCare [4] |
| Cash, Wegovy HD pen, 7.2 mg | $399 a month | Selected adult weight-management option; not the dose for every indication or age | NovoCare [4] |
| Cash, pill, 1.5 mg | $149 a month | One 30-tablet bottle | NovoCare [4] |
| Cash, pill, 4 mg | $199 a month | One 30-tablet bottle | NovoCare [4] |
| Cash, pill, 9 or 25 mg | $299 a month | One 30-tablet bottle | NovoCare [4] |
| Commercial plan covers it, with savings card | As little as $25 | Maximum savings $100 a month | NovoCare [4] |
| Medicare GLP-1 Bridge | $50 copay | July 2026 through December 2027, eligible Part D enrollees | CMS [6] |
| TrumpRx | Pen $199, pill $149 (lowest deals) | TrumpRx shows $1,349 as the “Original Price” | TrumpRx [7] |
| Patient Assistance Program | Not available | Wegovy isn’t on the 2026 product list | Novo Nordisk [5] |
NovoCare defines a month as one box of 4 pens or one bottle of 30 tablets [4]. Prices as currently listed.
Without insurance, the pen costs $349 a month at most doses
Paying cash through NovoCare Pharmacy, the Wegovy pen costs $349 a month at 0.25, 0.5, 1, 1.7 or 2.4 mg, and $399 a month for the 7.2 mg Wegovy HD pen [4]. The offer defines a month as one box of four pens, ordinarily four weekly doses rather than a calendar month. Clinical care is a separate budget question.
New patients get a lower start. NovoCare’s terms: patients new to the offer “pay $199 for each month of 0.25 mg & 0.5 mg. Offer for 2 monthly fills through December 31, 2026, then $349 per month” [4]. Compared with two boxes at the current $349 offer, two qualifying introductory boxes cost $300 less. That arithmetic is not a promise of eligibility, future pricing or the prescribed dose.
The current listed continuing pen offer is the same across 0.25–2.4 mg, while the 7.2 mg offer is higher. Someone on 2.4 mg pays what someone on 0.5 mg pays after the intro months. To get these prices, you fill through NovoCare Pharmacy or take the savings offer to your own pharmacist.
| Payment dates | Price per four-pen box | Subtotal |
|---|---|---|
| First two eligible fills | $199 | $398 |
| Next twelve fills through day 364 | $349 | $4,188 |
| Fourteen payment dates in total | $4,586 |
Publisher arithmetic, not a promised annual price: assumes payment at enrollment, uninterrupted 28-day fills, two qualifying introductory boxes, then the current 0.25–2.4 mg offer unchanged. The last box covers time beyond day 365. Thirteen boxes cover 52 weeks, or 364 days; a fill on day 364 creates a fourteenth payment. Actual prescribing, refill timing and eligibility vary. The introductory offer expires and prices may change, so a real budget crossing that deadline needs a fresh quote [4].
Wegovy pills cost $149 to $299 a month
Wegovy tablets cost $149 a month at 1.5 mg, $199 at 4 mg and $299 at 9 mg or 25 mg, where a month is one 30-tablet bottle [4]. The $149 strength is an initiation dose; the 25 mg maintenance strength is currently $299 per 30 tablets. That is not interchangeable with a four-pen supply or the injection’s dose schedule. More on how the pill differs is on the oral semaglutide page.
The $1,349 reference figure is different from an eligible cash offer
TrumpRx shows $1,349 as Wegovy’s “Original Price,” next to its own deals of $199 for the pen and $149 for the pill (TrumpRx) [7]. Those deal prices match NovoCare’s starting prices. These are advertised starting offers, not a promise of eligibility or a continuing maintenance price. A reference price does not establish what most patients actually pay.
Insurance coverage depends on your plan and the reason it’s prescribed
Whether insurance covers Wegovy depends on your plan’s formulary (its covered-drug list), not on your insurer’s name. Coworkers and neighbors with the same insurer may hear different answers, because employers choose different plans, and an employer can decide whether its plan covers weight-loss drugs.
The reason for the prescription can matter too. Wegovy’s indications depend on the formulation and population [8]. One is cutting the risk of heart attack, stroke and cardiovascular death in adults who have heart disease plus obesity or overweight. Another is weight management over the long term. The MASH indication is restricted to the injection in adults with noncirrhotic disease and moderate to advanced fibrosis, under accelerated approval. The tablet’s weight and cardiovascular indications are adult-only; pediatric weight treatment uses the injection. The 7.2 mg option is for selected adults needing additional weight reduction, not every indication. Ask the plan about the exact formulation, prescribed use and supporting records.
| Step | What to ask | Why |
|---|---|---|
| 1 | Is Wegovy on my plan’s formulary, and at what tier? | The formulary decides coverage and your copay |
| 2 | Does it need prior authorization? | The plan may need your prescriber to justify it first |
| 3 | Does my plan exclude drugs used for weight loss? | Some plans cover only other uses |
| 4 | What records does it need, such as BMI or a heart-disease diagnosis? | The plan may ask your prescriber to send them |
| 5 | Do I have to try another drug first (step therapy)? | Some plans require it |
With coverage, the savings card can bring Wegovy to $25
If your commercial insurance covers Wegovy, the savings offer lets you “pay as little as $25, subject to a maximum savings of $100/month” [4]. The cap is the catch. If your plan leaves you $300 to pay, the card takes off $100 and you still owe $200. On a high-deductible plan, that can mean paying more than the $349 cash price until you meet your deductible.
The $25 copay is for commercial, non-government insurance. NovoCare adds that government-insured patients “may use this program if they self pay and process outside of their insurance” [4]. In other words, someone on Medicare can still pay the cash price, just not the $25 copay.
Medicare: the GLP-1 Bridge charges $50 a month
Regular Part D generally excludes drugs used for weight loss. That is different from Wegovy prescribed for a Part D-coverable indication, such as cardiovascular risk reduction in adults with established cardiovascular disease and obesity or overweight. CMS says those requests remain with the Part D plan’s coverage and exception processes [3]. A diagnosis does not guarantee approval of every formulation or dose.
The Medicare GLP-1 Bridge is a separate demonstration. CMS calls it “a short-term demonstration” that gives eligible Part D enrollees access to certain GLP-1 drugs “between July 1, 2026, and December 31, 2027” [6]. The copay is $50 for a one-month supply, which Medicare defines as 28 or 30 days depending on the drug [2]. Because the Bridge runs outside Part D, your deductible is skipped, the $50 won’t count toward your yearly out-of-pocket limit, and Extra Help (the low-income subsidy) doesn’t apply. The Medicare Prescription Payment Plan cannot spread this copayment either [2].
NovoCare says eligible Medicare patients pay $50 a month for Wegovy through the Bridge, and that “this pricing is for adult patients with Medicare prescribed Wegovy for weight loss only” [4]. CMS sets the eligibility rules and runs prior authorization through a central processor [6], so check whether you qualify before counting on the $50 price.
Wegovy is absent from the reviewed manufacturer assistance list
Wegovy isn’t on Novo Nordisk’s Patient Assistance Program product list for 2026. The list includes Ozempic, the company’s diabetes brand of semaglutide, but not Wegovy [5]. That list does not establish that nobody can receive the drug without a personal payment. Ask the insurer, benefits administrator or a legitimate assistance program about the particular circumstances. Never assume that a coupon or an advertised free consultation includes free medication.
Compare medication offers and clinical-care charges separately
The cited manufacturer offer is one purchasing route. A pharmacy or clinic may have a different cash quote, service fee, membership or eligibility condition; compare the complete written offer rather than assuming every seller must honor the same total. For a store like CVS, Walmart or Costco, ask the pharmacist what it charges cash for your dose and set that against NovoCare’s $349.
Ask a clinic to separate its first visit, recurring membership, laboratory work and medication charge. Confirm whether membership continues during a treatment pause, whether the prescription can go to a pharmacy you choose, and what cancellation stops. A provider’s prescription review does not guarantee insurance approval or manufacturer-offer eligibility. Compare the Found review and other provider reviews for service questions, rather than borrowing a medicine quote from a different plan. The cost calculator separates recurring intervals from upfront payments; the insurance coverage guide explains formulary and authorization checks.
Will Wegovy get cheaper? The intro prices are due for an update
NovoCare says its pricing is “to be updated after December 31, 2026,” when the $199 intro offer also ends [4]. The current terms do not establish the next price. A budget that crosses the offer deadline needs a new quote; today’s figure is not a guaranteed year-long contract.
Some compounded offers have lower advertised prices, but compounded semaglutide is a different preparation. It is not FDA-approved, and FDA does not review it for safety, effectiveness or quality before marketing [1]. Its prices are in compounded semaglutide cost, and how to get it is in how to get compounded semaglutide. For the same molecule under its diabetes label, see Ozempic cost without insurance. For tirzepatide, see Zepbound cost. Safety is covered in is Wegovy safe, and the drug itself on the Wegovy and semaglutide pages.